Alyeska Investment Group, L.P. Gamida Cell Ltd. Transaction History

Alyeska Investment Group, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$3.93 - $4.59 $2.8 Million - $3.27 Million	-711,964 Reduced 64.89%	385,187 $1.6 Million
Q2 2020 Aug 14, 2020	BUY	$2.79 - $6.5 $2.46 Million - $5.74 Million	883,198 Added 412.8%	1,097,151 $5.01 Million
Q1 2020 May 15, 2020	BUY	$2.9 - $4.76 $132,866 - $218,084	45,816 Added 27.25%	213,953 $646,000
Q4 2019 Feb 14, 2020	SELL	$4.01 - $5.25 $50,377 - $65,955	-12,563 Reduced 6.95%	168,137 $722,000
Q3 2019 Nov 14, 2019	SELL	$3.0 - $5.09 $121,587 - $206,292	-40,529 Reduced 18.32%	180,700 $782,000

Q2 2019 Aug 14, 2019	BUY	$4.98 - $11.32 $1.1 Million - $2.5 Million	221,229 New	221,229 $0

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.